Clolar and dehydration Patient Reports February 13, 2012
Clolar Side Effects Report #6066255-5
Clolar side effect was reported by a Physician from UNITED STATES on Jan 27, 2009. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Clolar. After drug was administered, patient experienced the following side effects: dehydration, disease progression, excoriation, fluid intake reduced, hyponatraemia, hypophagia, insomnia, oral pain, oropharyngeal pain. Clolar dosage: unknown. During the same period patient was treated with ACYCLOVIR, ALLOPURINOL, FLUCONAZOLE, LORAZEPAM, NYSTATIN, OXYCODONE, OXYCONTIN, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 01/16/2009.
Clolar Side Effects Report #6083359-1
Clolar side effect was reported by a Physician from UNITED STATES on Feb 06, 2009. Female patient, 73 years of age, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: dehydration, fatigue, haematocrit decreased, haemoglobin decreased, nausea
, neutropenia, neutropenic infection, red blood cell count decreased, thrombocytopenia. Clolar dosage: 19 MG, QDX5; INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO, PRILOSEC. Patient was hospitalized. Patient recovered.Clolar Side Effects Report #6086994-X
Clolar side effect was reported by a Physician from UNITED STATES on Feb 11, 2009. Female patient, 73 years of age, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: bronchial wall thickening, bronchitis
, cardiomegaly, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, hyponatraemia, nausea
. Clolar dosage: 19 MG, QDX5, INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO. Patient was hospitalized. Patient recovered.Clolar Side Effects Report #6099444-4
Clolar side effect was reported by a Physician from UNITED STATES on Feb 18, 2009. Female patient, 73 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: blood sodium decreased, bronchial wall thickening, bronchitis
, cardiomegaly, dehydration, haematocrit decreased, haemoglobin decreased, nausea
, neutropenia. Clolar dosage: 19 MG, QDX5, INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO, PRILOSEC. Patient was hospitalized. Patient recovered.Clolar Side Effects Report #6110635-6
Clolar side effect was reported by a Physician from UNITED STATES on Feb 26, 2009. Female patient, 73 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: bronchitis
, cardiomegaly, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, nausea
, neutropenic infection, pneumonia
. Clolar dosage: 19 MG, QDX5, INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO. Patient was hospitalized. Patient recovered.Clolar Side Effects Report #4740483-0
Clolar side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 28, 2005. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: arrhythmia
, atrial fibrillation
, cardiac arrest
, creatinine renal clearance increased, dehydration, diarrhoea, dyspnoea, effusion. Clolar dosage: 20 MG/M2 QD X 5 IV. During the same period patient was treated with CLOFARABINE, VORICONAZOLE, AMIODARONE, METRONIDAZOLE, ACYCLOVIR, POTASSIUM CHLORIDE, METOCLOPRAMIDE, LINEZOLID. Patient was hospitalized. Patient died on 06/11/2005.Clolar Side Effects Report #6132663-7
Clolar side effect was reported by a Physician from UNITED STATES on Mar 17, 2009. Male patient, 42 years of age, weighting 286.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: adrenal insufficiency, blood pressure decreased, bone marrow transplant
, dehydration, dizziness
, haematocrit decreased, haemoglobin decreased, red blood cell count decreased, white blood cell count decreased. Clolar dosage: 85 MG, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN, ACTIGALL, ACYCLOVIR, ABILIFY, WELLBUTRIN, CLOBETASOL, FLUCONAZOLE, KEPPRA. Patient was hospitalized. Patient recovered.Clolar Side Effects Report #6058170-8
Clolar side effect was reported by a Physician from AUSTRIA on Dec 22, 2008. Female patient, 51 years of age, was diagnosed with acute leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: blast cell count decreased, dehydration, epidermolysis, hypoproteinaemia, lung infection pseudomonal, neutropenia, pneumonia primary atypical, staphylococcal infection
. Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, NEXAVAR, NEXIAM, UNASYN, HYDAL, VALTREX, CIPROXIN, NOXAFIL. Patient was hospitalized. Patient recovered.Clolar Side Effects Report #5874597-9
Clolar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2008. Male patient, weighting 198.4 lb, was treated with Clolar. After drug was administered, patient experienced the following side effects: anaemia, dehydration, escherichia infection, febrile neutropenia, multi-organ failure, organising pneumonia, pneumonia primary atypical, sepsis
. Clolar dosage: 425 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.Clolar Side Effects Report #6120549-3
Clolar side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2009. Male patient, weighting 198.4 lb, was treated with Clolar. After drug was administered, patient experienced the following side effects: anaemia, dehydration, escherichia sepsis, febrile neutropenia, hypoxia, multi-organ failure, organising pneumonia, skin lesion, thrombocytopenia. Clolar dosage: 425 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Clolar and dehydration 